Sumant Ramachandra - Director at Lyell Immunopharma, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
LYEL on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Sumant Ramachandra - trading volume in the past year for Lyell Immunopharma, Inc.

Holdings reported by Sumant Ramachandra for Lyell Immunopharma, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 200K $115K $0.58 Mar 21, 2025 Grantor and Trustee
Option (right to buy) 260K Oct 31, 2024 Direct Common Stock

Transactions reported by Sumant Ramachandra for Lyell Immunopharma, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.